Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Accumulated Expenses (2016 - 2026)

Kewaunee Scientific (KEQU) has 15 years of Accumulated Expenses data on record, last reported at $7.6 million in Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 105.39% year-over-year to $7.6 million; the TTM value through Oct 2025 reached $7.6 million, up 105.39%, while the annual FY2025 figure was $9.2 million, 52.44% up from the prior year.
  • Accumulated Expenses reached $7.6 million in Q4 2025 per KEQU's latest filing, down from $7.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $9.2 million in Q2 2025 and bottomed at $3.1 million in Q3 2024.
  • Average Accumulated Expenses over 5 years is $5.2 million, with a median of $4.7 million recorded in 2021.
  • Peak YoY movement for Accumulated Expenses: crashed 36.79% in 2024, then skyrocketed 151.66% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $4.1 million in 2021, then rose by 5.51% to $4.3 million in 2022, then rose by 16.27% to $5.0 million in 2023, then fell by 25.99% to $3.7 million in 2024, then soared by 105.39% to $7.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Expenses were $7.6 million in Q4 2025, $7.8 million in Q3 2025, and $9.2 million in Q2 2025.